Impact of IL-2 on Treatment Tolerance in Patients With High-Risk Neuroblastoma Treated With Dinutuximab Beta-Based Immunotherapy

por Cicek, Filiz, Troschke-Meurer, Sascha, Ceylan, Kiraz, Jahns, Luciana J., Zumpe, Maxi, Siebert, Nikolai, Ehlert, Karoline, Lode, Holger N.
Publicado 2020